文献速递中医内科中药与中成药合理使用

逍遥散治疗高血压疗效与安全性的系统评价与Meta分析

Efficacy and safety of Chinese herbal medicine Xiao Yao San in hypertension: A systematic review and meta-analysis.
PubMed 文献 · Phytomedicine · 2019-01-29

该系统评价与Meta分析检索7个电子数据库截至2019年1月7日的随机对照试验,纳入17项试验共1460例高血压患者。汇总分析显示逍遥散联合降压药在血压、焦虑抑郁量表、血脂、同型半胱氨酸及C反应蛋白方面优于单用降压药,但方法学缺陷使疗效与安全性仍不确定。

要点

  • 逍遥散联合降压药可能有助于降低血压、改善抑郁、调节血脂并抑制炎症。
  • 逍遥散联合降压药与单用降压药在主要心脑血管事件上未见显著差异。
  • 因方法学缺陷,逍遥散的疗效与安全性仍需长期双盲随机对照试验验证。

核心结论

  • 逍遥散作为降压药的辅助治疗可能对高血压患者降低血压、改善抑郁、调节血脂和抑制炎症有益。
  • 由于方法学缺陷,逍遥散的疗效与安全性仍不确定。

研究设计与样本

  • 系统评价与Meta分析,检索7个电子数据库从建库至2019年1月7日的随机对照试验。
  • 共纳入17项试验、1460例高血压患者。
  • 采用Cochrane干预系统评价手册独立评估方法学质量。

主要发现

  • 汇总分析显示逍遥散联合降压药在血压、汉密尔顿焦虑量表、焦虑自评量表、抑郁自评量表、9项患者健康问卷量表、总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、同型半胱氨酸和C反应蛋白方面优于对照组。
  • 逍遥散联合降压药与单用降压药在主要心脑血管事件上未见显著差异。
  • 逍遥散在高血压治疗中耐受性良好。

临床怎么用

  • 在高血压患者中可考虑将逍遥散作为降压药的辅助治疗,尤其伴焦虑抑郁或血脂异常者。
  • 使用逍遥散辅助治疗时仍需监测血压及主要心脑血管事件。

局限性

  • 纳入研究存在方法学缺陷,导致逍遥散的疗效与安全性仍不确定。
  • 未来需要更多长期、随机、双盲临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Xiao Yao San (XYS) is thought to be beneficial for the treatment of hypertension in China. PURPOSE: A systematic review and meta-analysis was performed to evaluate the efficacy and safety of XYS in hypertension. STUDY DESIGN: A comprehensive literature search was conducted in 7 electronic databases for randomized controlled trials from their inception until January 7, 2019. METHODS: Methodological quality was assessed independently using the Cochrane Handbook for Systematic Reviews of Interventions. RESULTS: A total of 17 trials including 1460 hypertensive patients met the selection criteria. Pooled analysis favored XYS plus antihypertensive drugs on blood pressure (BP), Hamilton anxiety scale, self-rating anxiety scale, self-rating depression scale, 9-item patient health questionnaire scale, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, homocysteine, and C-reactive protein. No significant difference between XYS plus antihypertensive drugs and antihypertensive drugs on major cardiovascular and cerebrovascular events was identified. XYS was well tolerated in the treatment of hypertension. CONCLUSION: XYS adjuvant to antihypertensive drugs maybe beneficial for hypertensive patients in lowering BP, improving depression, regulating blood lipids, and inhibiting inflammation. However, the efficacy and safety of XYS are still uncertain due to methodological shortcomings. More long-term, randomized, double-blinded clinical trials are needed in future studies.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Xiong X, Wang P, Duan L, et al. Efficacy and safety of Chinese herbal medicine Xiao Yao San in hypertension: A systematic review and meta-analysis. Phytomedicine. 2019. PMID: 31035044. doi:10.1016/j.phymed.2019.152849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。